SD Biotechnologies Co., Ltd. (KOSDAQ:A217480) agreed to acquire remaining 5.59% stake in Alpha B&H Co.,Ltd for KRW 45.7 million on May 30, 2019. An agreement is expected to be signed on June 4, 2019. SD Biotechnologies Co., Ltd. will acquire 0.08 million shares of Alpha B&H Co.,Ltd and will issue 0.0814299 shares for each share of Alpha B&H Co.,Ltd. SD Biotechnologies Co., Ltd. will issue 6179 million shares as consideration. After the transaction, SD Biotechnologies Co., Ltd. will be the surviving entity and Alpha B&H Co.,Ltd will be dissolved. Alpha B&H Co.,Ltd reported total assets of KRW 9.54 billion and net assets of KRW 2.19 billion as at December 31, 2018. Alpha B&H Co.,Ltd reported sales of KRW 2.49 billion and net loss of KRW 2.73 billion in 2018. The transaction is subject to approval of Board of Directors on July 4, 2019. The Board of Directors of SD Biotechnologies Co., Ltd. passed a resolution for the transaction on May 30, 2019. The transaction is expected to be completed on August 8, 2019.